Company Website:
http://www.zlk.com
NEW YORK -- (Business Wire)
The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired
securities of Lion Biotechnologies, Inc. ("Lion Biotechnologies")
(NASDAQ:LBIO) between November 14, 2013 and
April 10, 2017. You are hereby
notified that a securities class action lawsuit has been
commenced in the United States District Court for the Northern District
of California. To get more information go to:
http://www.zlk.com/pslra-sa/lion-biotechnologies-inc?wire=2
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There
is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued
materially false and/or misleading statements and/or failed to disclose
that: (1) through its former CEO Manish Singh, Lion was engaged in a
scheme to mislead investors by commissioning over 10 internet
publications and 20 widely distributed emails promoting the Company to
potential investors that purported to be independent from the company
when, in truth, they were paid promotions; (2) Singh engaged a notorious
stock promotion firm to pay writers to publish articles about Lion on
investment websites, as well as to coordinate the distribution of
articles to thousands of electronic mailboxes; (3) Singh actively
participated in the promotional work for the Company and understood that
the promotion firm was using writers who would not disclose that Lion
was indirectly compensating them for their publications; and (4)
consequently, defendants’ public statements were materially false and
misleading at all relevant times.
If you suffered a loss in Lion Biotechnologies you have until June
13, 2017 to request that the Court appoint you as lead
plaintiff. Your ability to share in any recovery doesn’t require that
you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York,
California, Connecticut, and Washington D.C. The firm’s attorneys have
extensive expertise and experience representing investors in securities
litigation, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170526005611/en/
Contacts:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street
- 24th Floor
New York, NY 10004
Tel: 212-363-7500
Toll
Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com
Source: Levi & Korsinsky, LLP
© 2024 Canjex Publishing Ltd. All rights reserved.